Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Alphatec Holdings Inc

Healthcare US ATEC

8.545USD
-0.005(0.06%)

Last update at 2026-06-23T18:32:00Z

Day Range

8.378.70
LowHigh

52 Week Range

10.1123.29
LowHigh

Fundamentals

  • Previous Close 8.55
  • Market Cap1586.22M
  • Volume1050530
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA19.53M
  • Revenue TTM764.16M
  • Revenue Per Share TTM5.09
  • Gross Profit TTM 531.89M
  • Diluted EPS TTM-0.87

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -143.40300M -162.07300M -186.91500M -152.00900M -144.16200M
Minority interest - - - - -
Net income -143.35800M -162.12300M -186.63800M -152.14900M -144.32600M
Selling general administrative 498.53M 450.20M 351.88M 300.01M 229.27M
Selling and marketing expenses - - - - -
Gross profit 531.89M 424.26M 310.20M 233.06M 157.76M
Reconciled depreciation 82.56M 83.32M 54.90M 43.93M 30.17M
Ebit -122.26200M -137.19400M -170.27400M -121.10200M -108.87200M
Ebitda -39.69900M -53.87400M -110.59200M -110.51600M -105.08700M
Depreciation and amortization 82.56M 83.32M 59.68M 10.59M 3.79M
Non operating income net other - - - - -
Operating income -82.12800M -136.16900M -173.39500M -121.10200M -108.87200M
Other operating expenses 846.28M 747.73M 655.66M 471.97M 352.08M
Interest expense 21.14M 24.88M 16.64M 5.50M 7.11M
Tax provision -0.04500M 0.05M 0.18M 0.14M 0.16M
Interest income - - - - -
Net interest income -45.92200M -24.87900M -13.55400M -5.50500M -7.10800M
Extraordinary items - - - - -
Non recurring - - - - 8.06M
Other items - - - - -
Income tax expense -0.04500M 0.05M -0.27700M 0.14M 0.16M
Total revenue 764.15M 611.56M 482.26M 350.87M 243.21M
Total operating expenses 614.02M 560.43M 483.60M 354.16M 266.63M
Cost of revenue 232.27M 187.30M 172.06M 117.81M 85.45M
Total other income expense net -61.27500M -25.90400M -13.52000M -30.90700M -35.29000M
Discontinued operations - - - - -
Net income from continuing ops -143.35800M -162.12300M -173.19900M -152.14900M -144.32600M
Net income applicable to common shares - - - -152.14900M -144.32600M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 791.21M 775.71M 805.21M 513.38M 572.05M
Intangible assets 93.45M 93.52M 102.45M 82.78M 85.27M
Earning assets - - - - -
Other current assets 23.32M 20.31M 20.67M 9.36M 10.31M
Total liab 755.18M 766.28M 703.49M 550.09M 492.63M
Total stockholder equity 36.03M 9.43M 101.72M -36.71300M 79.42M
Deferred long term liab - - - 1.30M -
Other current liab 97.02M 78.96M 87.71M 72.38M 55.55M
Common stock 0.01M 0.01M 0.01M 0.01M 0.01000M
Capital stock 0.01M 0.01M 0.01M 0.01M 0.01000M
Retained earnings -1424.44300M -1281.08500M -1118.96200M -934.47400M -782.32500M
Other liab - - - 11.54M 367.93M
Good will 75.21M 70.98M 73.00M 39.77M 39.69M
Other assets - - 0.00000M 4.87M 3.25M
Cash 160.81M 138.84M 220.97M 84.70M 187.25M
Cash and equivalents - - - - -
Total current liabilities 219.18M 153.03M 157.57M 138.87M 101.09M
Current deferred revenue 10.44M 10.47M 13.91M 11.96M 15.26M
Net debt 459.14M 471.10M 320.71M 311.17M -182.69400M
Short term debt 70.82M 8.11M 6.97M 19.79M 4.55M
Short long term debt 64.53M 1.66M 1.81M 14.95M 0.34M
Short long term debt total 619.95M 609.94M 541.68M 395.86M 4.55M
Other stockholder equity 1441.28M 1280.58M 1205.39M 884.84M 844.13M
Property plant equipment - - - 130.31M 112.68M
Total current assets 450.88M 417.40M 451.09M 255.63M 331.16M
Long term investments - - - - -
Net tangible assets - - - -159.26900M -45.54100M
Short term investments - - - - -
Net receivables 97.30M 82.99M 72.61M 60.06M 41.89M
Long term debt 501.41M 574.52M 511.04M 349.51M 326.49M
Inventory 169.44M 175.26M 136.84M 101.52M 91.70M
Accounts payable 40.89M 52.98M 48.98M 34.74M 25.74M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -4.42600M -13.67800M -8.32300M -10.69000M -5.99400M
Additional paid in capital - - - - -
Common stock total equity - - - - 0.01000M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -782.32500M
Treasury stock - - - - -25.09700M
Accumulated amortization - - - - -
Non currrent assets other 5.12M 2.72M 2.42M 4.87M 3.25M
Deferred long term asset charges - - - - -
Non current assets total 340.33M 358.31M 354.12M 257.74M 240.90M
Capital lease obligations 30.15M 33.76M 28.84M 31.40M 28.59M
Long term debt total - - - - 326.49M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -3.00000M -93.13600M -128.59700M -58.28000M -3.00000M
Change to liabilities - - - 7.52M 12.59M
Total cashflows from investing activities -53.41100M -93.13600M - -58.28000M -157.76200M
Net borrowings 74.81M 58.80M - 35.00M 306.22M
Total cash from financing activities 30.02M 56.21M 356.92M 31.23M 311.97M
Change to operating activities - - - 8.93M 13.25M
Net income -143.35800M -162.12300M -186.63800M -152.14900M -144.32600M
Change in cash 21.97M -82.13000M 136.27M -102.55200M 79.48M
Begin period cash flow 138.84M 220.97M 84.70M 187.25M 107.77M
End period cash flow 160.81M 138.84M 220.97M 84.70M 187.25M
Total cash from operating activities 45.23M -44.65100M -78.48500M -75.14300M -73.43200M
Issuance of capital stock 0.00000M 0.00000M 67.43M 57.51M 131.83M
Depreciation 105.08M 83.32M 59.68M 43.93M 30.17M
Other cashflows from investing activities -10.95600M -93.13600M - - -86.21800M
Dividends paid - - 1.06M 3.04M 316.25M
Change to inventory 13.54M -54.66000M -45.56200M -20.70400M -27.74600M
Change to account receivables -21.87900M -14.58900M -12.79500M -18.83200M -10.14100M
Sale purchase of stock - - -1.06400M -3.04100M -30.96300M
Other cashflows from financing activities -44.79500M -2.03200M -4.85600M -0.73100M 572.35M
Change to netincome - - - 54.13M 59.88M
Capital expenditures 42.45M 93.14M 86.97M 58.28M 68.54M
Change receivables - - - - -10.14100M
Cash flows other operating - - - - 7.69M
Exchange rate changes - - - - -1.28900M
Cash and cash equivalents changes - - - - 79.48M
Change in working capital -20.12900M -67.27400M -54.17800M -23.08900M -23.87600M
Stock based compensation 73.72M 73.28M 81.24M 40.56M 36.45M
Other non cash items 29.92M 28.15M 21.41M 15.61M 4.59M
Free cash flow 2.78M -137.78700M -165.46000M -133.42300M -141.97600M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ATEC
Alphatec Holdings Inc		 -0.005 0.06% 8.54 - 56.50 2.08 140.82 2.86 -18.8885
ABT
Abbott Laboratories		 2.70 3.07% 90.53 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 5.31 1.74% 310.00 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 1.36 1.72% 80.63 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 1.27 2.86% 45.60 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

Alphatec Holdings Inc

1950 Camino Vida Roble, Carlsbad, CA, United States, 92008

Key Executives

Name Title Year Born
Mr. Patrick S. Miles Exec. Chairman, CEO & Pres 1966
Mr. J. Todd Koning Exec. VP & CFO 1973
Mr. Craig E. Hunsaker Exec. VP of People & Culture, Corp. Sec. and Gen. Counsel 1964
Mr. Brian R. Snider Exec. VP of Marketing 1978
Mr. David P. Sponsel Exec. VP of Sales 1979
Mr. Jonathan Allen Exec. VP of Commercial Operations 1960
Mr. Scott Lish Sr. VP of R&D 1982
Dr. Luiz Pimenta Chief Medical Officer NA
Ms. Kelli Mari Howell Exec. VP of Clinical Strategies 1974
Mr. Eric Dasso Exec. VP of Adjunctive Technologies 1974

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.